Your browser doesn't support javascript.
loading
Equivalence testing of a newly developed interviewer-led telephone script for the EORTC QLQ-C30.
Piccinin, Claire; Pe, Madeline; Kulis, Dagmara; Shaw, James W; Wheelwright, Sally J; Bottomley, Andrew.
Afiliação
  • Piccinin C; Quality of Life Department, EORTC, Brussels, Belgium. claire.piccinin@eortc.org.
  • Pe M; Quality of Life Department, EORTC, Brussels, Belgium.
  • Kulis D; Quality of Life Department, EORTC, Brussels, Belgium.
  • Shaw JW; Patient-Reported Outcomes Assessment, Bristol-Meyers Squibb, Lawrenceville, NJ, USA.
  • Wheelwright SJ; Macmillan Survivorship Research Group, University of Southampton, Southampton, UK.
  • Bottomley A; Quality of Life Department, EORTC, Brussels, Belgium.
Qual Life Res ; 31(3): 877-888, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34286416
ABSTRACT

PURPOSE:

The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life-Core Questionnaire (QLQ-C30) is a widely used generic self-report measure of health-related quality of life (HRQOL) for cancer patients. However, no validated voice script for interviewer-led telephone administration was previously available. The aim of this study was to develop a voice script for interviewer administration via telephone.

METHODS:

Following guidelines from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) PRO Mixed Modes Good Research Practices Task Force, a randomised cross-over equivalence study, including cognitive debriefing, was conducted to assess equivalence between paper and telephone administration modes. Assuming an expected intraclass correlation coefficient (ICC) of 0.70 and a minimally acceptable level of 0.50, a sample size of 63 was required.

RESULTS:

Cognitive interviews with five cancer patients found the voice script to be clear and understandable. Due to a protocol deviation in the first wave of testing, only 26 patients were available for analyses. A second wave of recruitment was conducted, adding 37 patients (n = 63; mean age 55.48; 65.1% female). Total ICCs for mode comparison ranged from 0.72 (nausea and vomiting, 95% CI 0.48-0.86) to 0.90 (global health status/QoL, 95% CI 0.80-0.95; pain, 95% CI 0.79-0.95; constipation, 95% CI 0.80-0.95). For paper first administration, all ICCs were above 0.70, except nausea and vomiting (ICC 0.55; 95% CI 0.24-0.76) and financial difficulties (ICC 0.60; 95% CI 0.31-0.79). For phone first administration, all ICCs were above 0.70.

CONCLUSIONS:

The equivalence testing results support the voice script's validity for administration of the QLQ-C30 via telephone.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias Tipo de estudo: Clinical_trials / Guideline / Qualitative_research Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Qual Life Res Assunto da revista: REABILITACAO / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias Tipo de estudo: Clinical_trials / Guideline / Qualitative_research Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Qual Life Res Assunto da revista: REABILITACAO / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica